Am I eligible for this study? People who have bladder cancer that have the option to keep their bladder may be eligible for the study. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to your doctor to discuss your questions […]
Read MoreAbout This Study NRG-GU014, also known as the “PARRC” study, is a clinical study that will be testing if adding the immunotherapy drug called pembrolizumab to radiation therapy is better at controlling your cancer then compared to the usual chemotherapy treatment during radiation therapy for people with non-muscle invasive bladder cancer. Immunotherapy with monoclonal […]
Read MoreClinical Studies FAQ
Read MoreThe NRG-GU014 Study FAQ
Read More